Logo image of OLB

OLB GROUP INC (OLB) Stock Fundamental Analysis

NASDAQ:OLB - Nasdaq - US67086U4067 - Common Stock - Currency: USD

1.85  +0.09 (+5.11%)

After market: 1.93 +0.08 (+4.32%)

Fundamental Rating

1

OLB gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 100 industry peers in the Financial Services industry. OLB may be in some trouble as it scores bad on both profitability and health. OLB is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

OLB had negative earnings in the past year.
In the past year OLB has reported a negative cash flow from operations.
OLB had negative earnings in each of the past 5 years.
In the past 5 years OLB reported 4 times negative operating cash flow.
OLB Yearly Net Income VS EBIT VS OCF VS FCFOLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M

1.2 Ratios

Looking at the Return On Assets, with a value of -80.27%, OLB is doing worse than 97.00% of the companies in the same industry.
OLB has a worse Return On Equity (-438.09%) than 93.00% of its industry peers.
Industry RankSector Rank
ROA -80.27%
ROE -438.09%
ROIC N/A
ROA(3y)-76.28%
ROA(5y)-50.42%
ROE(3y)-190.05%
ROE(5y)-122.57%
ROIC(3y)N/A
ROIC(5y)N/A
OLB Yearly ROA, ROE, ROICOLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K -2K -4K

1.3 Margins

Looking at the Gross Margin, with a value of 16.63%, OLB is doing worse than 60.00% of the companies in the same industry.
In the last couple of years the Gross Margin of OLB has declined.
The Profit Margin and Operating Margin are not available for OLB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.39%
GM growth 5Y-13.39%
OLB Yearly Profit, Operating, Gross MarginsOLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

2

2. Health

2.1 Basic Checks

OLB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OLB has more shares outstanding
OLB has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, OLB has an improved debt to assets ratio.
OLB Yearly Shares OutstandingOLB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
OLB Yearly Total Debt VS Total AssetsOLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

OLB has an Altman-Z score of -9.13. This is a bad value and indicates that OLB is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -9.13, OLB is not doing good in the industry: 78.00% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.03 indicates that OLB is not too dependend on debt financing.
The Debt to Equity ratio of OLB (0.03) is better than 87.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -9.13
ROIC/WACCN/A
WACC8.75%
OLB Yearly LT Debt VS Equity VS FCFOLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

OLB has a Current Ratio of 0.08. This is a bad value and indicates that OLB is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of OLB (0.08) is worse than 78.00% of its industry peers.
A Quick Ratio of 0.08 indicates that OLB may have some problems paying its short term obligations.
OLB has a worse Quick ratio (0.08) than 78.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.08
Quick Ratio 0.08
OLB Yearly Current Assets VS Current LiabilitesOLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

1

3. Growth

3.1 Past

OLB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 65.79%, which is quite impressive.
Looking at the last year, OLB shows a very negative growth in Revenue. The Revenue has decreased by -57.50% in the last year.
The Revenue has been growing slightly by 4.52% on average over the past years.
EPS 1Y (TTM)65.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.39%
Revenue 1Y (TTM)-57.5%
Revenue growth 3Y-8.41%
Revenue growth 5Y4.52%
Sales Q2Q%-33.6%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OLB Yearly Revenue VS EstimatesOLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
OLB Yearly EPS VS EstimatesOLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 -0.5 -1 -1.5 -2 -2.5

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OLB. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OLB Price Earnings VS Forward Price EarningsOLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OLB Per share dataOLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

OLB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

OLB GROUP INC

NASDAQ:OLB (5/30/2025, 8:24:18 PM)

After market: 1.93 +0.08 (+4.32%)

1.85

+0.09 (+5.11%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)05-19 2025-05-19
Earnings (Next)08-12 2025-08-12
Inst Owners3.83%
Inst Owner Change-0.41%
Ins Owners28.61%
Ins Owner Change0%
Market Cap5.20M
Analysts80
Price Target30.6 (1554.05%)
Short Float %17.25%
Short Ratio0.35
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.45
P/FCF N/A
P/OCF N/A
P/B 2.27
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-5.07
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.83
FCFYN/A
OCF(TTM)-0.83
OCFYN/A
SpS4.15
BVpS0.82
TBVpS-2.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -80.27%
ROE -438.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.63%
FCFM N/A
ROA(3y)-76.28%
ROA(5y)-50.42%
ROE(3y)-190.05%
ROE(5y)-122.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.39%
GM growth 5Y-13.39%
F-Score3
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.08
Quick Ratio 0.08
Altman-Z -9.13
F-Score3
WACC8.75%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.39%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-57.5%
Revenue growth 3Y-8.41%
Revenue growth 5Y4.52%
Sales Q2Q%-33.6%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y39.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y28.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-208.43%
OCF growth 3YN/A
OCF growth 5YN/A